These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22655084)

  • 41. Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
    Chen Y; Feng S; Liu W; Yuan Z; Yin P; Gao F
    Mol Pharm; 2017 Apr; 14(4):1190-1203. PubMed ID: 28212490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual-targeting liposomes with active recognition of GLUT
    Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y
    Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
    Bianchi A; Arosio D; Perego P; De Cesare M; Carenini N; Zaffaroni N; De Matteo M; Manzoni L
    Org Biomol Chem; 2015 Jul; 13(27):7530-41. PubMed ID: 26074454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
    Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
    Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 99mTc-D(RGD): molecular imaging probe for diagnosis of αvβ3-positive tumors.
    Ramezanizadeh M; Masterifarahani A; Sadeghzadeh N; Abediankenari S; Mardanshahi A; Maleki F
    Nucl Med Commun; 2020 Feb; 41(2):104-109. PubMed ID: 31834256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.
    Eldar-Boock A; Blau R; Ryppa C; Baabur-Cohen H; Many A; Vicent MJ; Kratz F; Sanchis J; Satchi-Fainaro R
    J Drug Target; 2017; 25(9-10):829-844. PubMed ID: 28737432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. (18) F labeled RGD-A7R peptide for dual integrin and VEGF-targeted tumor imaging in mice bearing U87MG tumors.
    Ma Y; Liang S; Guo J; Guo R; Wang H
    J Labelled Comp Radiopharm; 2014 Sep; 57(11):627-31. PubMed ID: 25294311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent.
    Chakraborty S; Shi J; Kim YS; Zhou Y; Jia B; Wang F; Liu S
    Bioconjug Chem; 2010 May; 21(5):969-78. PubMed ID: 20387808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma.
    Ullah I; Chung K; Bae S; Li Y; Kim C; Choi B; Nam HY; Kim SH; Yun CO; Lee KY; Kumar P; Lee SK
    Mol Pharm; 2020 Apr; 17(4):1193-1204. PubMed ID: 31944768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αVβ3.
    Colombo R; Mingozzi M; Belvisi L; Arosio D; Piarulli U; Carenini N; Perego P; Zaffaroni N; De Cesare M; Castiglioni V; Scanziani E; Gennari C
    J Med Chem; 2012 Dec; 55(23):10460-74. PubMed ID: 23140358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1.
    Conradi J; Huber S; Gaus K; Mertink F; Royo Gracia S; Strijowski U; Backert S; Sewald N
    Amino Acids; 2012 Jul; 43(1):219-32. PubMed ID: 21915696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
    Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
    J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.
    Berghauser Pont LM; Kleijn A; Kloezeman JJ; van den Bossche W; Kaufmann JK; de Vrij J; Leenstra S; Dirven CM; Lamfers ML
    PLoS One; 2015; 10(5):e0127058. PubMed ID: 25993039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.
    Chen L; Liu Y; Wang W; Liu K
    Oncol Lett; 2015 Jul; 10(1):77-84. PubMed ID: 26170980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction.
    Tianqin G; Chunlei C; Jingjing W
    Biol Pharm Bull; 2016 Oct; 39(10):1623-1630. PubMed ID: 27431785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin α
    Liolios C; Sachpekidis C; Kolocouris A; Dimitrakopoulou-Strauss A; Bouziotis P
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33810198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fatty acid-RGD peptide amphiphile micelles as potential paclitaxel delivery carriers to α(v)β₃ integrin overexpressing tumors.
    Javali NM; Raj A; Saraf P; Li X; Jasti B
    Pharm Res; 2012 Dec; 29(12):3347-61. PubMed ID: 22825750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of apoptosis of integrin-expressing human prostate cancer cells by cyclic Arg-Gly-Asp peptides.
    Chatterjee S; Brite KH; Matsumura A
    Clin Cancer Res; 2001 Oct; 7(10):3006-11. PubMed ID: 11595688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model.
    Qi N; Zhou X; Ma N; Zhang J; Wang Z; Zhang X; Li A
    Int J Nanomedicine; 2024; 19():3071-3086. PubMed ID: 38562611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.